Investor Relations
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
Stock Information
Stock Quote []
Price
Change
Day High
Day Low
Volume
Copyright West LLC. Minimum 15 minutes delayed.
ICU Proxy Mailing Information
2021 Annual Report
2021 Annual Report 15.1 MB2022 Proxy Statement
2022 Proxy Statement 954.6 KB2022 Annual Report
2022 Annual Report 5.2 MB2023 Proxy Statement
2023 Proxy Statement 3.1 MB
Featured Report
There are no items to display.
Recent Releases
ICU Medical Announces Third Quarter 2023 Results
November 6, 2023
SAN CLEMENTE, Calif. , Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023 . Third Quarter 2023 Results Third quarter 2023
ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call
October 23, 2023
SAN CLEMENTE, Calif. , Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.
ICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
September 5, 2023
SAN CLEMENTE, Calif. , Sept. 05, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare
ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software
August 29, 2023
The clinician-driven design of the precision system is the foundation of ICU Medical’s long-term IV systems product road map that seeks to blend ease of use with proven medication delivery and safety San Clemente, Calif. Aug. 29, 2023 – ICU Medical Inc.
Recent Events
Nov 6, 2023 at 4:30 PM EST
ICU Medical, Inc. Third Quarter 2023 Earnings Conference Call
Learn More
Sep 12, 2023 at 7:30 AM EDT
Morgan Stanley 21st Annual Global Healthcare Conference ICU Medical’s presentation was cancelled due to illness
Learn More
Aug 7, 2023 at 4:30 PM EDT
ICU Medical, Inc. Second Quarter 2023 Earnings Conference Call
Learn More